“Evaluate the benefit effects of Dodonaea viscosa in kidney of infected rats with Staphylococcus aureus” (2022) Journal of Pharmaceutical Negative Results, 13(3), pp. 291–294. doi:10.47750/pnr.2022.13.03.046.